SNODGRASS H. RALPH 4
4 · VistaGen Therapeutics, Inc. · Filed Jan 3, 2022
Insider Transaction Report
Form 4
SNODGRASS H. RALPH
DirectorPRES./CHIEF SCIENTIFIC OFFICER
Transactions
- Award
Common Stock
2021-12-31$1.66/sh+3,623$6,005→ 64,958 total
Holdings
- 33,901(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Shares purchased under the VistaGen Therapeutics, Inc. 2019 Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c)